Search > Results

You searched for: EV230950 (EV-TRACK ID)

Showing 1 - 2 of 2

Experiment number
  • If needed, multiple experiments were identified in a single publication based on differing sample types, separation protocols and/or vesicle types of interest.
Species
  • Species of origin of the EVs.
Separation protocol
  • Gives a short, non-chronological overview of the different steps of the separation protocol.
    • (d)(U)C = (differential) (ultra)centrifugation
    • DG = density gradient
    • UF = ultrafiltration
    • SEC = size-exclusion chromatography
    • IAF = immuno-affinity capture
Details EV-TRACK ID Experiment nr. Species Sample type Separation protocol First author Year EV-METRIC
EV230950 1/2 Yersinia pseudotuberculosis ATCC 29833 (d)(U)C
DG
Filtration
UF
Monnappa AK 2018 50%

Study summary

Full title
All authors
Monnappa AK, Bari W, Seo JK, Mitchell RJ
Journal
Sci Rep
Abstract
In this study we show Yersinia pseudotuberculosis secretes membrane vesicles (MVs) that contain diff (show more...)In this study we show Yersinia pseudotuberculosis secretes membrane vesicles (MVs) that contain different proteins and virulence factors depending on the strain. Although MVs from Y. pseudotuberculosis YPIII and ATCC 29833 had many proteins in common (68.8% of all the proteins identified), those located in the outer membrane fraction differed significantly. For instance, the MVs from Y. pseudotuberculosis YPIII harbored numerous Yersinia outer proteins (Yops) while they were absent in the ATCC 29833 MVs. Another virulence factor found solely in the YPIII MVs was the cytotoxic necrotizing factor (CNFy), a toxin that leads to multinucleation of host cells. The ability of YPIII MVs to transport this toxin and its activity to host cells was verified using HeLa cells, which responded in a dose-dependent manner/ nearly 70% of the culture was multinucleated after addition of 5 µg/ml of the purified YPIII MVs. In contrast, less than 10% were multinucleated when the ATCC 29833 MVs were added. Semi-quantification of CNFy within the YPIII MVs found this toxin is present at concentrations of 5 ~ 10 ng per µg of total MV protein, a concentration that accounts for the cellular responses seen. (hide)
EV-METRIC
50% (87th percentile of all experiments on the same sample type)
 Reported
 Not reported
 Not applicable
EV-enriched proteins
Protein analysis: analysis of three or more EV-enriched proteins
non EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody specifics
Protein analysis: antibody clone/reference number and dilution
lysate preparation
Protein analysis: lysis buffer composition
Study data
Sample type
Cell culture supernatant
Sample origin
Control condition
Focus vesicles
MV (membrane vesicle)
Separation protocol
Separation protocol
  • Gives a short, non-chronological overview of the
    different steps of the separation protocol.
    • dUC = (Differential) (ultra)centrifugation
    • DG = density gradient
    • UF = ultrafiltration
    • SEC = size-exclusion chromatography
    • IAF = immuno-affinity capture
(Differential) (ultra)centrifugation
Density gradient
Filtration
Ultrafiltration
Protein markers
EV: Not applicable
non-EV: Not applicable
Proteomics
yes
Show all info
Study aim
Function/Identification of content (omics approaches)
Sample
Species
Yersinia pseudotuberculosis
Sample Type
Cell culture supernatant
EV-producing cells
ATCC 29833
EV-harvesting Medium
serum free medium
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Between 800 g and 10,000 g
Between 100,000 g and 150,000 g
Pelleting performed
Yes
Pelleting: rotor type
not specified
Pelleting: speed (g)
not spec
Density gradient
Type
Discontinuous
Number of initial discontinuous layers
6
Lowest density fraction
0%
Highest density fraction
40%
Total gradient volume, incl. sample (mL)
11.5
Sample volume (mL)
2
Orientation
Bottom-up
Speed (g)
100000
Duration (min)
960
Fraction volume (mL)
1
Fraction processing
None
Filtration steps
0.22µm or 0.2µm
Ultra filtration
Cut-off size (kDa)
100
Membrane type
Regenerated cellulose
Characterization: Protein analysis
Protein Concentration Method
Bradford
Proteomics database
No
Other 1
SDS-PAGE + Coomassie Blue staining
Detected EV-associated proteins
Not applicable
Not detected EV-associated proteins
Not applicable
Detected contaminants
Not applicable
Not detected contaminants
Not applicable
Characterization: Lipid analysis
No
Characterization: Particle analysis
EM
EM-type
Transmission­-EM
Image type
Wide-field
Report size (nm)
70-150
EV230950 2/2 Yersinia pseudotuberculosis YPIII (d)(U)C
DG
Filtration
UF
Monnappa AK 2018 50%

Study summary

Full title
All authors
Monnappa AK, Bari W, Seo JK, Mitchell RJ
Journal
Sci Rep
Abstract
In this study we show Yersinia pseudotuberculosis secretes membrane vesicles (MVs) that contain diff (show more...)In this study we show Yersinia pseudotuberculosis secretes membrane vesicles (MVs) that contain different proteins and virulence factors depending on the strain. Although MVs from Y. pseudotuberculosis YPIII and ATCC 29833 had many proteins in common (68.8% of all the proteins identified), those located in the outer membrane fraction differed significantly. For instance, the MVs from Y. pseudotuberculosis YPIII harbored numerous Yersinia outer proteins (Yops) while they were absent in the ATCC 29833 MVs. Another virulence factor found solely in the YPIII MVs was the cytotoxic necrotizing factor (CNFy), a toxin that leads to multinucleation of host cells. The ability of YPIII MVs to transport this toxin and its activity to host cells was verified using HeLa cells, which responded in a dose-dependent manner/ nearly 70% of the culture was multinucleated after addition of 5 µg/ml of the purified YPIII MVs. In contrast, less than 10% were multinucleated when the ATCC 29833 MVs were added. Semi-quantification of CNFy within the YPIII MVs found this toxin is present at concentrations of 5 ~ 10 ng per µg of total MV protein, a concentration that accounts for the cellular responses seen. (hide)
EV-METRIC
50% (87th percentile of all experiments on the same sample type)
 Reported
 Not reported
 Not applicable
EV-enriched proteins
Protein analysis: analysis of three or more EV-enriched proteins
non EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody specifics
Protein analysis: antibody clone/reference number and dilution
lysate preparation
Protein analysis: lysis buffer composition
Study data
Sample type
Cell culture supernatant
Sample origin
Control condition
Focus vesicles
MV (membrane vesicle)
Separation protocol
Separation protocol
  • Gives a short, non-chronological overview of the
    different steps of the separation protocol.
    • dUC = (Differential) (ultra)centrifugation
    • DG = density gradient
    • UF = ultrafiltration
    • SEC = size-exclusion chromatography
    • IAF = immuno-affinity capture
(Differential) (ultra)centrifugation
Density gradient
Filtration
Ultrafiltration
Protein markers
EV: Not applicable
non-EV: Not applicable
Proteomics
yes
Show all info
Study aim
Function/Identification of content (omics approaches)
Sample
Species
Yersinia pseudotuberculosis
Sample Type
Cell culture supernatant
EV-producing cells
YPIII
EV-harvesting Medium
serum free medium
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Between 800 g and 10,000 g
Between 100,000 g and 150,000 g
Pelleting performed
Yes
Pelleting: rotor type
not specified
Pelleting: speed (g)
not spec
Density gradient
Type
Discontinuous
Number of initial discontinuous layers
6
Lowest density fraction
0%
Highest density fraction
40%
Total gradient volume, incl. sample (mL)
11.5
Sample volume (mL)
2
Orientation
Bottom-up
Speed (g)
100000
Duration (min)
960
Fraction volume (mL)
1
Fraction processing
None
Filtration steps
0.22µm or 0.2µm
Ultra filtration
Cut-off size (kDa)
100
Membrane type
Regenerated cellulose
Characterization: Protein analysis
Protein Concentration Method
Bradford
Proteomics database
No
Other 1
SDS-PAGE Coomassie Blue staining
Detected EV-associated proteins
Not applicable
Not detected EV-associated proteins
Not applicable
Detected contaminants
Not applicable
Not detected contaminants
Not applicable
Characterization: Lipid analysis
No
Characterization: Particle analysis
EM
EM-type
Transmission­-EM
Image type
Wide-field
Report size (nm)
70-150
1 - 2 of 2
  • CM = Commercial method
  • dUC = differential ultracentrifugation
  • DG = density gradient
  • UF = ultrafiltration
  • SEC = size-exclusion chromatography
EV-TRACK ID
EV230950
species
Yersinia
pseudotuberculosis
sample type
Cell culture
cell type
ATCC 29833
YPIII
condition
Control condition
Control condition
separation protocol
dUC/
Density gradient/
Filtration/
Ultrafiltration
dUC/
Density gradient/
Filtration/
Ultrafiltration
Exp. nr.
1
2
EV-METRIC %
50
50